Manfredi, F.; Chiozzini, C.; Ferrantelli, F.; Leone, P.; Giovannelli, A.; Sanchez, M.; Federico, M.
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein. Vaccines 2022, 10, 1060.
https://doi.org/10.3390/vaccines10071060
AMA Style
Manfredi F, Chiozzini C, Ferrantelli F, Leone P, Giovannelli A, Sanchez M, Federico M.
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein. Vaccines. 2022; 10(7):1060.
https://doi.org/10.3390/vaccines10071060
Chicago/Turabian Style
Manfredi, Francesco, Chiara Chiozzini, Flavia Ferrantelli, Patrizia Leone, Andrea Giovannelli, Massimo Sanchez, and Maurizio Federico.
2022. "Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein" Vaccines 10, no. 7: 1060.
https://doi.org/10.3390/vaccines10071060
APA Style
Manfredi, F., Chiozzini, C., Ferrantelli, F., Leone, P., Giovannelli, A., Sanchez, M., & Federico, M.
(2022). Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein. Vaccines, 10(7), 1060.
https://doi.org/10.3390/vaccines10071060